PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 77 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $903 | -99.9% | 483,000 | +40.0% | 1.43% | +25.5% |
| Q3 2022 | $887,000 | -7.1% | 345,000 | -30.3% | 1.14% | +0.5% |
| Q2 2022 | $955,000 | -11.4% | 495,000 | +36.4% | 1.13% | -33.5% |
| Q1 2022 | $1,078,000 | -8.5% | 363,000 | +38.4% | 1.70% | +12.1% |
| Q4 2021 | $1,178,000 | -0.1% | 262,279 | +8.2% | 1.52% | -4.5% |
| Q3 2021 | $1,179,000 | +3.2% | 242,514 | +44.8% | 1.59% | +1.2% |
| Q2 2021 | $1,142,000 | -5.5% | 167,492 | -2.2% | 1.57% | +14.9% |
| Q1 2021 | $1,209,000 | -0.8% | 171,270 | -12.1% | 1.37% | -33.6% |
| Q4 2020 | $1,219,000 | +44.9% | 194,789 | +25.4% | 2.06% | +12.8% |
| Q3 2020 | $841,000 | +149.6% | 155,373 | +140.9% | 1.83% | +99.7% |
| Q2 2020 | $337,000 | +198.2% | 64,500 | +193.2% | 0.92% | +1170.8% |
| Q4 2018 | $113,000 | -78.8% | 22,000 | -46.3% | 0.07% | -64.0% |
| Q1 2018 | $533,000 | – | 40,977 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $16,279,000 | 2.44% |
| Abingworth LLP | 1,041,131 | $6,517,000 | 2.23% |
| Telemetry Investments, L.L.C. | 194,789 | $1,219,000 | 2.06% |
| AIGH Capital Management LLC | 749,608 | $4,692,000 | 1.91% |
| Trellus Management Company, LLC | 340,000 | $2,128,000 | 1.76% |
| Bruce & Co., Inc. | 929,312 | $5,817,000 | 1.12% |
| Worth Venture Partners, LLC | 191,093 | $1,196,000 | 0.95% |
| GENERAL AMERICAN INVESTORS CO INC | 1,000,751 | $6,265,000 | 0.62% |
| Weil Company, Inc. | 104,907 | $657,000 | 0.39% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 140,020 | $877,000 | 0.29% |